R&D Systems™ Recombinant Human VAP-1 Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human VAP-1 Protein is derived from Sf 21 (baculovirus). The Recombinant Human VAP-1 Protein has been validated for the following applications: Enzyme Activity.

Specifications

• Formulation: Supplied as a 0.2μm filtered solution in HEPES and NaCl.
• Gene ID (Entrez): 8639
• Molecular Weight (g/mol): 85 kDa
• Name: VAP-1/AOC3
• Quantity: 10 μg
• Source: Spodoptera frugiperda,Sf 21 (baculovirus)-derived human VAP-1/AOC3 protein Gly27-Asn763,with an N-terminal Met and 10-His tag,followed by a Gly-Gly-Gly-Ser-Gly-Gly-Gly-Ser-Gly-Gly-Gly-Ser-Ile-Glu-Gly-Arg linker
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70° C as supplied. 3 months, -20 to -70° C under sterile conditions after opening.
• Structural Form: Disulfide-linked homodimer
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: 95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie™ Blue stain at 5 μg per lane.